A flow-cytometric method to investigate glutamate-receptor-sensitivity in whole blood platelets - Results from healthy controls and patients with schizophrenia

被引:14
作者
Baier, Paul C. [1 ]
Koch, Jakob M. [1 ]
Seeck-Hirschner, Mareen [1 ]
Ohlmeyer, Kathrin [1 ]
Wilms, Sibylle [1 ]
Aldenhoff, Josef B. [1 ]
Hinze-Selch, Dunja [1 ]
机构
[1] Univ Kiel, Dept Psychiat & Psychotherapy, D-24105 Kiel, Germany
关键词
Blood platelets; Human; Schizophrenia; Metabotropic quisqualate receptor; N-Methyl-D-Aspartate (NMDA) receptor; Neuroleptic drugs; CALCIUM MOBILIZATION; PLASMA GLUTAMATE; RICH PLASMA; NMDA; MODEL; ACTIVATION; TRANSPORT; DOPAMINE; NEURON;
D O I
10.1016/j.jpsychires.2008.07.005
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Hypofunction of glutamate receptors may contribute to the symptoms of schizophrenia. Human platelets express glutamate receptors and can serve as peripheral surrogate model for neuronal cells. Aim of this study was to establish a fast and sensitive flow-cytometric method to determine the glutamate-dependent kinetics of intracellular calcium ([Ca++]i) mobilization in platelets of schizophrenic patients. Glutamate stimulated [Ca++]i response was measured with a flow-cytometer in anti-CD-41a-labelled whole blood platelets of treated schizophrenic patients (n = 18) and controls (n = 18). In two control experiments the NMDA-receptor antagonist MK-801 and the dopamine antagonist amisulpride, respectively, were added to probes from healthy subjects. Stimulation with glutamate led dose-dependently to a mobilization of [Ca++]i in both healthy controls and patients. This effect was significantly reduced in patients. In vitro NMDA-antagonism inhibited the glutamate response, whereas dopamine-antagonism had no effect. Our flow-cytometric method allows to measure glutamate-receptor mediated [Ca++]i response in whole blood platelets, without requiring platelet rich preparations. The reduced glutamate-response in the patients was not explained by a direct inhibitory treatment effect. However, further studies with drug naive patients will be necessary to find out whether or not the observed hypoglutamergic function of platelets is endogenous to the disorder. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:585 / 591
页数:7
相关论文
共 37 条
[1]   STUDIES ON THE EFFECT OF DOPAMINE ON THE HUMAN PLATELET RESPONSE [J].
ANFOSSI, G ;
MASSUCCO, P ;
MULARONI, E ;
CAVALOT, F ;
BURZACCA, S ;
MATTIELLO, L ;
TROVATI, M .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1992, 19 (09) :613-618
[2]  
Belsham B, 2001, HUM PSYCHOPHARM CLIN, V16, P139, DOI 10.1002/hup.279.abs
[3]   Supersensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia [J].
Berk, M ;
Plein, H ;
Csizmadia, T .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1999, 14 (02) :119-122
[4]   Platelet glutamate receptor supersensitivity in major depressive disorder [J].
Berk, M ;
Plein, H ;
Ferreira, D .
CLINICAL NEUROPHARMACOLOGY, 2001, 24 (03) :129-132
[5]   Organochalcogens affect the glutamatergic neurotransmission in human platelets [J].
Borges, VC ;
Nogueira, CW ;
Zeni, G ;
Rocha, JBT .
NEUROCHEMICAL RESEARCH, 2004, 29 (08) :1505-1509
[6]  
Cazenave Jean-Pierre, 2004, Methods Mol Biol, V272, P13
[7]  
Coyle JT, 2004, INT REV NEUROBIOL, V59, P491
[8]  
DAPRADA M, 1988, EXPERIENTIA, V44, P115
[9]   ELEVATED PLATELET CALCIUM MOBILIZATION AND NITRIC-OXIDE SYNTHASE ACTIVITY MAY REFLECT ABNORMALITIES IN SCHIZOPHRENIC BRAIN [J].
DAS, I ;
KHAN, NS ;
PURI, BK ;
SOORANNA, SR ;
DEBELLEROCHE, J ;
HIRSCH, SR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 212 (02) :375-380
[10]   Changes in [3H]-glutamate uptake into platelets from patients with bipolar I disorder [J].
do Nascimento, CAM ;
Nogueira, CW ;
Borges, VC ;
Rocha, JBT .
PSYCHIATRY RESEARCH, 2006, 141 (03) :343-347